UK Faculty

John A. Armitstead, MS, RPH, FASHP
Director, Pharmacy Services, UK HealthCare

Assistant Dean, UK College of Pharmacy

Carrie L. Johnson, PharmD, CDE
Assistant Professor, Pharmacy Practice and Science
Clinical Pharmacist, PharmacistCARE

Russ Judd, PharmD
PY2 Infectious Diseases Specialty Resident, UK Healthcare
Chair, Kentucky Konnection Committee
Co-chair, Residency Recruitment Committee, UK HealthCare Pharmacy Residency Program

Daniel Lewis, PharmD
Therapeutic Drug Monitoring Pharmacy Specialist, Pharmacy Services, UKMC
Adjunct Assistant Professor, Pharmacy Practice and Science Department, UK College of Pharmacy

Craig Martin, PharmD, BCPS
Adjunct Assistant Professor, Pharmacy Practice and Science Department, UK College of Pharmacy
Clinical Pharmacy Specialist-Infectious Diseases, Pharmacy Services, UK HealthCare

Trenika Mitchell, PharmD, BCPS
Lecturer, Pharmacy Practice and Science Department, UK College of Pharmacy
Clinical Staff Pharmacist, UKMC

Amy S. Nicholas, PharmD, CDE
Co-director, PharmacistCARE
Associate Professor, Pharmacy Practice and Science Department, UK College of Pharmacy
Assistant Coordinator, Geriatrics Elective and Nutrition, Non-Prescription and Advanced Therapeutics Courses

Peggy Piascik, RPh, PhD
Associate Professor, Pharmacy Practice and Science Department, UK College of Pharmacy

Kenneth B. Roberts, RPh, PhD, MBA
Dean, UK College of Pharmacy

Frank Romanelli, PharmD, MPH, BCPS
Assistant Dean for Education, UK College of Pharmacy
Associate Professor, Pharmacy Practice and Science Department, UK College of Pharmacy

Associate Professor, Physician Assistant Studies (Joint Appointment), Division of Clinical Sciences, UK College of Allied Health
Clinical Specialist in HIV/AIDS, UKMC

David W. Rudy, MD
Assistant Professor, Medicine, UK College of Medicine

Daniel Wermeling, PharmD, FASHP
Associate Professor, Pharmacy Practice and Science Department, UK College of Pharmacy
Associate Professor (Joint Appointment), Department of Neurology, UK College of Medicine
Neurology Clinical Pharmacy Specialist, Lexington VAMC
            
Guest Faculty

Peter P. Cohron, RPh, JD
Associate Professor (part-time), UK College of Pharmacy
Attorney, Private Practice
Lexington, Kentucky

Brooke Hudspeth, PharmD
Staff Pharmacist            
Kroger Pharmacy
Lexington, Kentucky

Patricia R. Jennings, DrPH, PA-C
Physician Assistant, Jefferson County Health Department STD Clinic
Physician Assistant, UAB HIV/AIDS Clinic and the Birmingham Veterans Administration HIV Clinic
Birmingham, Alabama

Daniel A. Nadeau, MD
Medical Director, HealthReach Diabetes, Endocrine and Nutrition Center at Exeter Health Resources
Exeter, New Hampshire
Assistant Professor, Medicine, Tufts Medical School
Boston, Massachusetts

Pharmacists

• Discuss ethical and legal issues surrounding the use of lethal injection as a means of state-sanctioned execution
• Review technical and clinical aspects of the pharmacotherapy involved in lethal injection
• Discuss the role of preventive medicine in the aging male
• Evaluate new studies and impact on the treatment of benign prostatic hyperplasia
• Assess the role of chemoprevention to reduce the risk of prostate cancer
• Analyze approaches to improve safety and efficacy in the treatment of erectile dysfunction
• Determine how “green” is your pharmacy
• Identify steps in identifying ways to minimize the pharmaceutical impact on the environment
• Counsel consumers on how to discard unwanted pharmaceuticals
• Describe the epidemiology of chlamydia, gonorrhea, HSV and syphilis in the US
• Describe the pathogenesis of C. trachomatis, N. gonorrhea and T. pallidum
• Discuss the clinical manifestations, including complications and long term sequela of syphilis, HSV, chlamydial and gonococcal infections
• Identify common methods used in the diagnosis of syphilis, HSV, chlamydial and gonococcal infections
• Describe public health measures for the prevention of STDs
• Describe the most recently marketed drug and delivery systems being employed in pain management
• Describe the technological advances in development intended to minimize drug abuse from prescription medications
• Describe new antimicrobial agents and/or new therapeutic uses of established agents
• Discuss recent trends in antimicrobial resistance
• Identify the tools essential for effective pharmacist/physician collaboration
• Identify the necessary components of a formal collaborative care agreement in Kentucky
• Review current dyslipidemia management strategies and discuss the role of lipoprotein parameters other than LDL or non-HDL in lipid management
• Discuss the results of the recent ENHANCE trial and how this will affect therapy decisions
• Examine new therapies for treating dyslipidemia that are under active development
• Discuss the pathogenesis of the influenza virus as well as prevention and treatment of infection
• Describe the background and threat of a potential H5N1 influenza pandemic
• Describe extended cycle oral contraceptive characteristics including dosing regimen, indications, potential advantages and common adverse effects
• Discuss contemporary issues with hormonal contraceptives including the Ortho Evra patch, desogestrel-containing products and efficacy of products in obese patients
• Review the epidemiology of H. pylori
• Explain the significance of H. pylori in the etiology and pathophysiology of peptic ulcer disease
• Discuss diagnostic tests for H. pylori
• Compare and contrast therapeutic strategies employed in H. pylori management
• Assess state-of-the-art management of Type 2 diabetes with a focus on weight loss and reduction of cardiovascular risk with some focus on optimal nutrition
• Review the use of incretin mimetics, metformin and long-acting insulin in treating Type 2 diabetes
• Review use of insulin and incretin mimetic pens and related devices
• Discuss ways of minimizing side effects of these classes of medications
• Discuss the PharmacistCARE Program and nuances of establishing a Medication Therapy Management (MTM) Service
• Discuss the outcomes of the PharmacistCARE Diabetes Care Program to date
• Discuss new and recent pharmacy-related issues from legislative and administrative sources
• Review recent court cases and the legal issues thereof regarding pharmacists and pharmacies
  

Technicians

• Review the drug classes typically employed in state-sanctioned lethal injection
• Describe the technical aspects of lethal injection as it is usually accomplished in the US
• Discuss the role of preventive therapies in men’s health
• Review current medications for the management of BPH and erectile dysfunction
• Identify the most commonly encountered STDs in the US
• Describe symptoms associated with the most common STDs in the US
• Recognize drug classes commonly used to treat STDs
• Describe the most recently marketed drug and delivery systems being employed in pain management
• Describe the technological advances in development intended to minimize drug abuse from prescription medications
• Describe the need for pharmacist/physician collaboration utilizing a diabetes case example
• Discuss the value of pharmacists’ collaboration with physicians and other prescribers and the role of each provider
• Describe the different types of pens and devices for delivering drug therapy for the management of diabetes
• Discuss the overall management of the patient with diabetes, including weight loss and cardiovascular risk reduction
• Identify the need for pharmacists to establish Medication Therapy Management (MTM) Services
• Review the components needed to establish MTM Services
• Discuss new and recent pharmacy-related issues from legislative and administrative sources
• Review recent court cases and the legal issues thereof regarding pharmacists and pharmacies

This program has been assigned ACPE # 022-000-08-109-L03-P, 022-000-08-110-L01-P, 022-000-08-111-L04-P, 022-000-08-112-L02-P, 022-000-08-113-L01-P, 022-000-08-114-L01-P, 022-000-08-115-L04-P, 022-000-08-116-L01-P, 022-000-08-117-L01-P, 022-000-08-118-L01-P, 022-000-08-119-L01-P, 022-000-08-120-L01-P, 022-000-08-122-L03-P, 022-000-08-121-L04-P and will award up to 15 contact hours (1.5 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

Statements of credit will indicate hours and CEUs based on participation and will be issued online at the conclusion of the activity. Successful completion includes signing in at registration, attending the entire session for which credit is claimed, completing the activity evaluation and requesting credit online at conclusion of the activity. The College complies with the Accreditation Standards for Continuing Pharmacy Education.

Pharmacy Technician
The University of Kentucky College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This activity has been assigned ACPE # 022-000-08-109-L03-T, 022-000-08-110-L01-T, 022-000-08-112-L02-T, 022-000-08-113-L01-T, 022-000-08-115-L04-T, 022-000-08-120-L01-T, 022-000-08-122-L03-T, 022-000-08-121-L04-T and will award up to 9 contact hours (0.9 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

Statements of credit will indicate hours and CEUs based on participation and will be issued online at the conclusion of the activity. Successful completion includes completing the activity, its accompanying evaluation and/or posttest (score 70% or higher) and requesting credit online at conclusion of the activity. The College complies with the Accreditation Standards for Continuing Pharmacy Education.

Registration fees include online educational materials, a continuing education statement of credit, lunch on Friday, breakfast and breaks each day.

By October 10, 2008

Entire Conference - $250.00
Friday Only - $145.00
Saturday Only - $125.00
Sunday Only - $55.00
Pharmacy Law Only - $35.00
Friday & Saturday - $270.00
Saturday & Sunday - $180.00
Guest Lunch Friday - $21.00

After October 10, 2008
Entire Conference - $275.00    
Friday Only - $155.00
Saturday Only - $135.00
Sunday Only - $75.00
Pharmacy Law Only - $55.00
Friday & Saturday - $290.00
Saturday & Sunday - $200.00
Guest Lunch Friday - $21.00

Refund Policy

A refund less a $25.00 processing fee will be issued if written notice of withdrawal is received by October 3, 2008. No refund will be granted after that date. Registration may be transferred to another participant.

The Colleges of Pharmacy and Medicine Continuing Education Office reserves the right to cancel or make substitutions in this activity. A full refund will be issued if circumstances warrant cancellation.

All sessions will be held at the Crowne Plaza Campbell House Inn, 1375 Harrodsbrug Road, Lexington, KY  40504 (800) 354-9235. A block of sleeping rooms has been reserved at the rate of $139+ tax per night single/double occupancy. Reservation deadline is September 26, 2008. Reservations made after that date will be on a space/rate available basis. Be sure to request the UK College of Pharmacy group rate to receive the conference rate. Visit http://www.thecambellhouse.net for complete hotel information and directions.